TrueBlue (TBI) PT Raised to $26 at BMO Capital
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $10.20 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 21
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 21
Join SI Premium – FREE
BMO Capital analyst Jeffrey Silber raised the price target on TrueBlue (NYSE: TBI) to $26.00 (from $25.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) PT Lowered to $25 at H.C. Wainwright
- Snowflake Inc. (SNOW) PT Raised to $450 at Needham
- Snowflake Inc. (SNOW) PT Raised to $425 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
